Pandion Therapeutics, Inc.
Records under this name other than the patents Pandion Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 10 of 10 · Back to Pandion Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,676,516 | Targeted immunotolerance Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,961,310 | Targeted immunotolerance Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,466,068 | Targeted immunotolerance Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,174,091 | IL-2 muteins Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,174,092 | IL-2 Muteins Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,091,527 | IL-2 Muteins and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,945,852 | IL-2 muteins and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,779,632 | IL-2 muteins and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,739,146 | MAdCAM targeted immunotolerance Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,946,068 | IL-2 muteins and uses thereof Formerly held Surrendered on reissue Surrendered on reissue Aug 26, 2025 · USPTO record | Surrendered on reissue | Surrendered on reissue Aug 26, 2025 | USPTO record |